An alert was issued by the Kwango Provincial Health Division, DRC, after reports from civil society organizations in March 2023 regarding a resident with skin rashes and pruritus. Teams from the National Programme for the Control of Monkeypox and Viral Hemorrhagic Fevers and the Institut National de Recherche Biomédicale, accompanied by members of the senior team from the Kwango Provincial Health Division, the senior team from the Kenge Health Zone, the provincial team from the National Programme for the Control of HIV, and the provincial civil society representative, conducted an investigation. During the investigation, the national and provincial health teams instituted training for local healthcare clinics to raise awareness of the clinical signs and mode of transmission for mpox and HIV, including sexual contact in MSM.

A man from DRC in his late 20s (case-patient 1) reported having 2 sexual encounters with a man (suspected primary case-patient) in Europe 1 week before returning to DRC. The suspected primary case-patient frequently visited DRC. Case-patient 1 reported that the primary case-patient had general clinical symptoms including genital pruritus, joint pain, and physical asthenia. Nine days after contact, case-patient 1 began experiencing pruritus, vesicular skin eruptions, and genital and perianal ulcerations. He contacted a local civil organization, which initiated a preliminary investigation and alerted the National Programme for the Control of Monkeypox and Viral Hemorrhagic Fevers. He had penile lesions and penile papules (Figure 1); localized redness on the lips and in the oral buccal mucosa were also noted, and he had 1 lesion on the middle finger of the right hand. Blood samples, oropharyngeal swab samples, swab samples from rectal and genital lesions, and swab samples from vesicles on the skin of the penis and pubis were taken.

Case-patient 1 reported having sexual contact with 9 partners (6 men and 3 women) after arriving in DRC. A prescreening of those contacts identified suspected mpox in 3 sexual contacts (2 men and 1 woman, 30–35 years of age) who had fever and lesions in the genital and perianal region. Blood samples and oropharyngeal swab samples were taken from all 9 partners; additional rectal or vaginal swab samples were taken from the men and woman suspected to be secondary case-patients. Investigation of all sexual contacts yielded an additional 36 sexual contacts. Samples from case-patient 1 and 3 suspected secondary case-patients were confirmed to be MPXV-positive by PCR using samples from vesicles, crusts, or blood. One of the 36 sexual contacts was also PCR-positive for MPXV. We performed viral genome sequencing on PCR-positive samples; phylogenetic analysis showed tight clustering among 3 positive samples, suggesting they belong to the same chain of transmission. The closest related sequence beyond this cluster was a 2022 clade I MPXV sequence from DRC (Figure 2).

We treated the 5 PCR-positive case-patients with supportive care and pain control on an outpatient basis. We performed a follow-up investigation to further investigate transmission chains and identify additional contacts; follow-up was conducted for each contact through individual case report forms. We monitored a total of 120 contacts over 21 days. The contacts were categorized into 3 groups: sexual contacts (n = 5), family members (n = 45), and persons associated with close nonsexual contact (n = 70). None of the persons monitored during the 21 days experienced clinical signs.

We describe a cluster of clade I MPXV–associated infections in DRC related to sexual contact, which has previously only been described for clade II MPXV. Of note, MPXV transmission through sexual contact is not exclusive to clade IIb and can occur during heterosexual and same-sex contact. This study demonstrates that MPXV infections can occur through additional exposure routes in MPXV-endemic regions and that the current understanding of mpox burden in clade I–endemic regions is based on classical transmission exclusively; recognizing those factors is critical. Our findings highlight additional considerations for MPXV circulation and transmission containment in endemic areas. Thus, increased MPXV surveillance, diagnostic testing access, and equitable access to both vaccines and therapeutics for persons at increased risk for infection are needed for ongoing mitigation strategies. Given the increased disease severity associated with clade I MPXV, the potential implications of sexual transmission on broadening geographic distribution for MPXV across clades I and II must be considered. In addition, long-term immunity to mpox inferred by vaccination is unknown, including the role of mucosal immunity against clade I MPXV infections. This report highlights multiple critical global health considerations that must be addressed. Ongoing support for community engagement and educational efforts focusing on mpox recognition and reporting, including within sexual networks and for specific groups who might suffer from lack of care or experience stigma when seeking care.

Our findings highlight historically unrecognized MPXV transmission through sexual contact and indicate the need for increased routine screening in sexual health clinics in mpox-endemic and nonendemic regions. Population movement and previously unreported routes of transmission could exacerbate global distribution of MPXV, which could be compounded by the lack of routine diagnostic testing or inadequate access to rapid point-of-care testing. In view of this investigation, epidemiologic and genomic surveillance for MPXV, in both endemic and nonendemic regions, should be improved and strengthened.